Perm Medical JournalPerm Medical JournalПермский медицинский журнал (сетевое издание "Perm medical journal")0136-14492687-1408Eco-Vector339810.17816/pmj301121-127ArticlesСтатьиReview ArticlePREGNANCY ASSOCIATED PHEOCHROMOCYTOMA: Review of literatureФЕОХРОМОЦИТОМА, АССОЦИИРОВАННАЯ С БЕРЕМЕННОСТЬЮ: ОБЗОР ЛИТЕРАТУРЫKolevatovA PКолеватовАркадий Петрович

заведующий отделением анестезиологии и реаниматологии ГБУЗ КМСЧ №1 Пермского края, кандидат медицинских наук, доцент кафедры хирургических болезней медико-профилактического факультета

samson2003@inbox.ruShevchukE VШевчукЕлена Владимировна

анестезиолог – реаниматолог отделения анестезиологии и реаниматологии ГБУЗ КМСЧ №1

ZarivchatskyM FЗаривчацкийМихаил Федорович

доктор медицинских наук, профессор, заведующий кафедрой хирургических болезней медико-профилактического факультета

Пермскаягосударственная медицинская академия им. ак. Е.А. ВагнераКлиническая медико-санитарная часть №1, г. Пермь15022013301VOL 30, NO1 (2013)ТОМ 30, №1 (2013)12112712072016Copyright ©; 2013, Kolevatov A.P., Shevchuk E.V., Zarivchatsky M.F.Copyright ©; 2013, Колеватов А.П., Шевчук Е.В., Заривчацкий М.Ф.2013Kolevatov A.P., Shevchuk E.V., Zarivchatsky M.F.Колеватов А.П., Шевчук Е.В., Заривчацкий М.Ф.http://creativecommons.org/licenses/by-sa/4.0https://permmedjournal.ru/PMJ/article/view/3398

The paper presents analysis of epidemiology, diagnosis, urgent therapy and preoperative preparation for treatment of a rare, but actual regarding potential threat for life, pathology – pregnancy associated pheochromocytoma.

В работе представлен анализ эпидемиологии, диагностики, неотложной терапии и предоперационной подготовки редкой, но актуальной в связи с потенциальной угрозой жизни патологии – феохромоцитомы, ассоциированной с беременностью.

Pheochromocytomapregnancyarterial hypertensiondoxasosinurapidilФеохромоцитомабеременностьартериальная гипертензиядоксазозинурапидилAhn J. T., Hibbard J. U., Chapa J. B. Atypical presentation of phaeochromocytoma as part of multiple endocrine neoplasiaIIa in pregnancy. Obstet Gynecol 2003; 102: 1202–1205.Aplin S. C., Yee K. F., Cole M. J. Neonatal effects of long-term maternal phenoxybenzamine therapy. Anesthesiology 2004; 100: 1608–1610.Brain K. L., Kay J., Shine B. Measurement of urinary metanephrines to screen for phaeochromocytoma in an unselected hospital referral population. Clin. Chem. 2006; 52: 2060–2064.Brunt L. M. Phaeochromocytoma in pregnancy. Br. J. Surg. 2001; 88: 481–483.Duley L., Smart Henderson-D. J., Meher S. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database of Systematic Reviews 2006; Issue 3: Art. No. CD001449. DOI: 10.1002/14651858.CD001449.pub2.Desai A. S., Chutkow W. A., Edelman E. Clinical problem-solving. A crisis in late pregnancy. N. Engl. J. Med. 2009; 361: 2271–2277.Dugas G., Fuller J., Singh S. Pheochromocytoma and pregnancy: a case report and review of anesthetic management. Can. J. Anaesth. 2004; 51: 134–138.Golden S. H., Robinson K. A., Saldanha I. J. Clinical review: prevalence and incidence of endocrine and metabolic disorders in the United States–a comprehensive review. Clin Endocrinol. Metab. 2009; 94: 1853–1878.Grodski S., Jung C., Kertes P. Phaeochromocytoma in pregnancy. Intern. Med. J. 2006; 36: 604–606.Grossman A., Pacak K., Sawka A. Biochemical diagnosis and localization of phaeochromocytoma: can we reach a consensus? Ann. N. Y. Acad. Sci. 2006; 1073: 332–347.James M. F., Cronje L. Phaeochromocytoma crisis: the use of magnesium sulfate. Anaesth. Analg. 2004; 99: 680–686.Junglee N., Harries S. E., Davies N. Pheochromocytoma in pregnancy: when is operative intervention indicated? J. Womens Health (Larchmt) 2007; 16: 1362–1365.Kalra J. K., Jain V., Bagga R. Pheochromocytoma associated with pregnancy. Obstet Gynaecol. Res. 2003; 29: 305–308.Kariya N., Nishi S., Hosono Y. Cesarean section at 28 weeks’ gestation with resection of pheochromocytoma: perioperative antihypertensive management. J. Clin. Anesth. 2005; 17: 296–299.Kim J., Reutrakul S., Davis D. B. Multiple endocrine neoplasia 2A syndrome presenting as peripartum cardiomyopathy due to catecholamine excess. Eur. J. Endocrinol. 2004; 151: 771–777.Lenders J. W., Eisenhofer G., Mannelli M. Phaeochromocytoma. Lancet 2005; 366: 665–675.Lenders J. W., Pacak K., Huynh T. T. Low sensitivity of glucagon provocative testing for diagnosis of phaeochromocytoma. J. Clin. Endocrinol. Metab. 2010; 95: 238–245.Lenders J. W., Pacak K., Walther M. M. Biochemical diagnosis of phaeochromocytoma: which test is best? J.A.M.A. 2002; 287: 1427–1434.Lindheimer M. D., Taler S. J., Cunningham F. G. ASH position paper: hypertension in pregnancy. J. Clin. Hypertens (Greenwich) 2009; 11: 214–225.Lindsay J. R., Nieman L. K. Adrenal disorders in pregnancy. Endocrinol. Metab. Clin. N. Am. 2006; 35: 1.Mannelli M., Bemporad D. Diagnosis and management of phaeochromocytoma during pregnancy. J. Endocrinol. Invest. 2002; 25: 567–571.Oliva R., Angelos P., Kaplan E. Phaeochromocytoma in pregnancy: a case series and review. Hypertension 2010; 55: 600–606.Plouin P. F., Duclos J. M., Soppelsa F. Factors associated with perioperative morbidity and mortality in patients with phaeochromocytoma: analysis of 165 operations at a single center. J. Clin. Endocrinol. Metab. 2001; 86: 1480–1486.Reisch N., Peczkowska M., Januszewicz A. Pheochromocytoma: presentation, diagnosis and treatment. J. Hypertens. 2006; 24: 2331–2339.Tran H. A. Pheochromocytoma during pregnancy. Endocr. Pract. 2004; 10: 382–383.Yumi H. Guidelines for diagnosis, treatment, and use of laparoscopy for surgical problems during pregnancy: this statement was reviewed and approved by the Board of Governors of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), September 2007. It was prepared by the SAGES Guidelines Committee. Surg. Endosc. 2008; 22: 849–861.